The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of the COVID-19 pandemic on staging and treatment patterns in non-small cell lung cancer: A large national study.
 
Logan Spiegelman
No Relationships to Disclose
 
Zouina Sarfraz
No Relationships to Disclose
 
Lydia Hodgson
No Relationships to Disclose
 
Fatma Nihan Akkoc Mustafayev
No Relationships to Disclose
 
Khalis Mustafayev
No Relationships to Disclose
 
Mohammad Arfat Ganiyani
No Relationships to Disclose
 
Julia Steger
No Relationships to Disclose
 
Ian Bostock
No Relationships to Disclose
 
Nicole Eiseler
Consulting or Advisory Role - Daiichi Sankyo; Deciphera; SpringWorks Therapeutics
 
Rupesh Kotecha
Honoraria - BrainLAB; Elekta; IBA; InSightec; Kazia Therapeutics; Novocure; ViewRay
Consulting or Advisory Role - Novocure; ViewRay
Speakers' Bureau - GT Medical Technologies (I); Novocure
Research Funding - AstraZeneca (Inst); Blue Earth Diagnostics (Inst); BrainLAB (Inst); Cantex Pharmaceuticals, Inc. (Inst); Exelixis (Inst); GT Medical Technologies (Inst); IBA (Inst); Kazia Therapeutics (Inst); Medtronic (Inst); Novocure (Inst); ViewRay (Inst)
Travel, Accommodations, Expenses - BrainLAB; Elekta; Novocure; ViewRay
Other Relationship - GT Medical Technologies Data Safety Monitoring Board; InSightec Advisory Board; Plus Therapeutics Data Safety Monitoring Board
 
Manmeet Ahluwalia
Stock and Other Ownership Interests - doctible; MedInnovate Advisors LLC; MimiVax; TriSalus Life Sciences
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - AlloVir; Anheart Therapeutics; Apollomics; Autem Therapeutics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; Equillium; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; Siemens Healhineers/Varian Medical Systems; Sumitomo Dainippon Pharma Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)